epirubicin
mitomycin c
BCG
none of the above
C. BCG
ascending urethrography
voiding cystourethrography
MRI
IVU
obstructive LUTS are common presentations and occur in association with carcinoma in situ
might present as perineal abscesses and fistulae
could be asymptomatic
venereal diseases increase the risk of urethral cancers
bladder perforation
obturator nerve reflex
vesico-ureteral reflux
terrible bleeding
the lesion is solitary and no associated CIS
physically, a surgical margin of 2-cm can be obtained
the resected area should be far enough from ureteral orifices and the bladder neck
all of the following
the anterior urethra drains into the inguinal and pelvic nodes
the posterior urethra drains into the pelvic nodes
the proximal two-thirds drain into the external and internal iliac nodes
the distal one-third drains into the obturator nodes
often of high-grade sarcomas
often associated with muscularis propria invasion
due to vesical polyps occluding ureteric orifices
should be resected but not diathermized
leiomyoma
hemangioma
fibroepithelial polyp
lymphangioma
multifocality
high tumor grade and advanced stage
presence of CIS
all of the above
adenocarcinoma
transitional cell carcinoma
squamous cell carcinoma
basal cell carcinoma
well-differentiated tumor with broad-based invasive font
marked atypia distributed on wide areas of superficial urothelium
atypia is present
no atypia but marked degenerative epithelial changes
transitional cell carcinoma
squamous cell carcinoma
adenocarcinoma
small cell carcinoma
tumor stage
tumor grade
lymphovascular invasion
lymph node spread
2 - 4%
4 - 6%
6 - 8%
8 - 10%
patients with carcinoma in situ
patients with completely resected solitary tumor
patients with preserved kidney and liver functions after 2 courses of BCG
patients with leiomyosarcoma
adenocarcinoma
transitional cell carcinoma
squamous cell carcinoma
basal cell carcinoma
obesity
consuming artificial sweeteners
asbestosis
analgesic abuse
single intravesical chemotherapy
TURBT
intravesical BCG vaccine
multiple bladder biopsies
there will be no target tumor tissue to work on
post-op. hematuria interacts unfavorably with BCG composition
of the risk of systemic absorption and sepsis
of the high risk of BCG reflux to kidneys while bladder irrigation
en bloc resection involving total penectomy, cystoprostatectomy, resection of the pubic rami and urogenital diaphragm, with pelvic lymphadenectomy. In addition, creating a urinary diversion.
total penectomy involving removal of the penis, urethra, and penile root
partial penectomy involving excision of the malignant lesion with 2-cm margins
transurethral resection or fulguration
undergo cystectomy
try mitomycin c
take a second course of BCG
take a second course of BCG + quinolones
RB
cyclin A
HRAS
CD-44
frequently found in association with high-grade or extensive TCC
has a rate of progression to muscle invasion of 10-25%
significant areas of CIS are easily missed by routine cystoscopy
treatment begins with TURBT
increase the irrigation fluid and pursue the procedure
abort the procedure and leave a urethral catheter
perform cystogram and manage accordingly
perform abdominal exploration and manage accordingly
leiomyosarcoma
rhabdosarcoma
carcinosarcoma
neurosarcoma
sensitivity to chemotherapy and age at presentation
anatomic location and extent of the tumor
histologic type of the tumor and sensitivity to radiotherapy
tumors stage and grade
0.6 - 2%
2 - 6%
6 - 10%
12 - 16%
obstructive uropathy
painless hematuria
pain radiating to the groin
locally advanced tumor
mid prostate to the verumontanum at the 5 and 7 oclock positions
lateral margins of the prostate at the 10 and 2 oclock positions
entire area distal to the urethral crest
area between ejaculatory duct openings and prostatic utricle
urine cytology
CT urography
cystoscopy
renal function tests
working with organic chemicals and dyes
abuse of pain-control medications especially phenacetin
exposure to arsenic and aromatic amines
schistosomiasis